Investigation of the Impact of Medications Used in COVID-19 Treatment and COVID-19 Vaccine on Hearing
NCT ID: NCT07254442
Last Updated: 2025-11-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
90 participants
OBSERVATIONAL
2021-12-01
2022-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of the Effectiveness of Oral and Intratympanic Corticosteroid Treatments in Patients Diagnosed With Sudden Sensorineural Hearing Loss
NCT06968507
The Influence of Covid-19 on the Audio-vestibular System
NCT04709146
Audio Vestibular Functions in COVID 19 Patients in Sohag Governate
NCT04860193
The Effects of Chronic Otitis Surgery on SVV
NCT04396145
Transtympanic Gentamicin vs. Steroids in Refractory Meniere's Disease
NCT00802529
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
Group that has not had Covid-19
Hearing tests
Participants' pure tone thresholds, high frequency thresholds, and otoacoustic emissions measurements were evaluated.
Medication Group
The group that had Covid-19 and used medication
Hearing tests
Participants' pure tone thresholds, high frequency thresholds, and otoacoustic emissions measurements were evaluated.
Non-medication group
The group that had Covid-19 and did not use medication
Hearing tests
Participants' pure tone thresholds, high frequency thresholds, and otoacoustic emissions measurements were evaluated.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hearing tests
Participants' pure tone thresholds, high frequency thresholds, and otoacoustic emissions measurements were evaluated.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zonguldak Bulent Ecevit University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Azize Arzu KÖROĞLU KOÇYİĞİT
Audiologist, Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Biruni University
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1919B012102481
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2021/61-18
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.